DG (Directorate General) Research on embryonic stem cell issues:
This article was originally published in Clinica
Executive Summary
The issues surrounding human embryonic stem cell research are tackled in a report just released by the European Commission's Directorate General Research. The paper examines the scientific, ethical, socio-economic and governance aspects of human stem cell research and outlines the potential benefits of such research and the pros and cons of using stem cells from different sources. It reviews the current state of legislation in various EU member states and some non-EU countries as well as the governance of human stem cell research under the European Commission's Sixth Framework Programme.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.